Stryker Tries To Limit Bone Device Marketing Charges

Law360, New York (September 22, 2010, 2:08 PM EDT) -- Stryker Biotech LLC and four current and former executives are seeking to trim criminal allegations that they falsely marketed devices used in invasive bone surgeries, arguing that federal prosecutors brought the charges in the wrong venue.

Seven of the 16 counts in the federal indictment arise out of alleged conduct — a Stryker Biotech employee's instruction to a surgeon, hospital or sales representative — that indisputably took place outside Massachusetts, precluding the government from trying these counts in the U.S. District Court for the District of...
To view the full article, register now.